OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor-Derived Small Extracellular Vesicles Inhibit the Efficacy of CAR T Cells against Solid Tumors
Wenqun Zhong, Zebin Xiao, Zhiyuan Qin, et al.
Cancer Research (2023) Vol. 83, Iss. 16, pp. 2790-2806
Open Access | Times Cited: 27
Wenqun Zhong, Zebin Xiao, Zhiyuan Qin, et al.
Cancer Research (2023) Vol. 83, Iss. 16, pp. 2790-2806
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy
Guangtan Du, Cunmiao Dou, Peng Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Guangtan Du, Cunmiao Dou, Peng Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Advances in exosomes utilization for clinical applications in cancer
Inês A. Batista, José Carlos Machado, Sónia A. Melo
Trends in cancer (2024) Vol. 10, Iss. 10, pp. 947-968
Closed Access | Times Cited: 7
Inês A. Batista, José Carlos Machado, Sónia A. Melo
Trends in cancer (2024) Vol. 10, Iss. 10, pp. 947-968
Closed Access | Times Cited: 7
Application of exosomes in tumor immunity: recent progresses
Haiyan Qiu, Junting Liang, Guang Yang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Haiyan Qiu, Junting Liang, Guang Yang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 6
Engineered biological nanoparticles as nanotherapeutics for tumor immunomodulation
Juwita N. Rahmat, Jiayi Liu, Taili Chen, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 11, pp. 5862-5903
Open Access | Times Cited: 6
Juwita N. Rahmat, Jiayi Liu, Taili Chen, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 11, pp. 5862-5903
Open Access | Times Cited: 6
Dendritic cell-derived exosomes (Dex): Underlying the role of exosomes derived from diverse DC subtypes in cancer pathogenesis
Gulixian Tuluwengjiang, Irodakhon Rasulova, Shamim Ahmed, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155097-155097
Closed Access | Times Cited: 5
Gulixian Tuluwengjiang, Irodakhon Rasulova, Shamim Ahmed, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155097-155097
Closed Access | Times Cited: 5
The small extracellular vesicle‐mediated intercellular transformation of CXCR1Low to CXCR1High tumour cells promotes the progression of head and neck squamous cell carcinoma
Qiaoshi Xu, Aoming Cheng, Bo Li, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 4
Open Access | Times Cited: 5
Qiaoshi Xu, Aoming Cheng, Bo Li, et al.
Journal of Extracellular Vesicles (2024) Vol. 13, Iss. 4
Open Access | Times Cited: 5
Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5
Yating Wu, Yue Cao, Li Chen, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 5
The Current Landscape of Secondary Malignancies after CAR T-Cell Therapies: How Could Malignancies Be Prevented?
Stella Bouziana, Dimitrios Bouzianas
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9518-9518
Open Access | Times Cited: 5
Stella Bouziana, Dimitrios Bouzianas
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9518-9518
Open Access | Times Cited: 5
MicroRNA-enriched exosome as dazzling dancer between cancer and immune cells
Chou‐Yi Hsu, Abdulrahman T. Ahmed, Pooja Bansal, et al.
Journal of Physiology and Biochemistry (2024)
Closed Access | Times Cited: 5
Chou‐Yi Hsu, Abdulrahman T. Ahmed, Pooja Bansal, et al.
Journal of Physiology and Biochemistry (2024)
Closed Access | Times Cited: 5
Tumor-Derived Extracellular Vesicles: Hijacking T cell Function through Exhaustion
Renhua Guo, Ping Wang
Pathology - Research and Practice (2025), pp. 155948-155948
Closed Access
Renhua Guo, Ping Wang
Pathology - Research and Practice (2025), pp. 155948-155948
Closed Access
The role of small Extracellular Vesicles (sEVs) and Rab27a in nanoparticle metastasis and tumor targeting
Jiahua Si, Xinming Su, Zhao-Hui Jin, et al.
The Innovation Medicine (2025), pp. 100126-100126
Closed Access
Jiahua Si, Xinming Su, Zhao-Hui Jin, et al.
The Innovation Medicine (2025), pp. 100126-100126
Closed Access
ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insights
Alaa M. Ali, John F. DiPersio
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Alaa M. Ali, John F. DiPersio
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Bisecting GlcNAc modification of vesicular GAS6 regulates CAFs activation and breast cancer metastasis
Jing Li, Xueting Ren, Lin Cao, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Jing Li, Xueting Ren, Lin Cao, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Biology of extracellular vesicles and the potential of tumor-derived vesicles for subverting immunotherapy of cancer
Theresa L. Whiteside
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010376-e010376
Open Access
Theresa L. Whiteside
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e010376-e010376
Open Access
Strategies to Overcome Antigen Heterogeneity in CAR-T Cell Therapy
Bohan Zhang, Jiawen Wu, Hua Jiang, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 320-320
Open Access
Bohan Zhang, Jiawen Wu, Hua Jiang, et al.
Cells (2025) Vol. 14, Iss. 5, pp. 320-320
Open Access
Genetic tools for investigating the life cycle of extracellular vesicles
Wenyi Zheng, Samantha Roudi, Houze Zhou, et al.
Nature Reviews Bioengineering (2025)
Closed Access
Wenyi Zheng, Samantha Roudi, Houze Zhou, et al.
Nature Reviews Bioengineering (2025)
Closed Access
Overcoming extracellular vesicle-mediated fratricide improves CAR T cell treatment against solid tumors
Wenqun Zhong, Zhiyuan Qin, Ziyan Yu, et al.
Nature Cancer (2025)
Closed Access
Wenqun Zhong, Zhiyuan Qin, Ziyan Yu, et al.
Nature Cancer (2025)
Closed Access
Evaluating therapeutic plasma exchange and protease inhibitors as mechanisms to reduce soluble mesothelin
Katherine E. Smith, Jennifer Ayers-Ringler, Jacob J. Orme, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Katherine E. Smith, Jennifer Ayers-Ringler, Jacob J. Orme, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A Group of Highly Secretory miRNAs Correlates with Lymph Node Metastasis and Poor Prognosis in Oral Squamous Cell Carcinoma
Yicun Li, Yuntao Lin, Xiaolian Li, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 224-224
Open Access | Times Cited: 3
Yicun Li, Yuntao Lin, Xiaolian Li, et al.
Biomolecules (2024) Vol. 14, Iss. 2, pp. 224-224
Open Access | Times Cited: 3
Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy
Siheng Zhang, Linglong Peng, Yifei Chen, et al.
Inflammation and Regeneration (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 3
Siheng Zhang, Linglong Peng, Yifei Chen, et al.
Inflammation and Regeneration (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 3
Exosomal microRNA as a key regulator of PI3K/AKT pathways in human tumors
Saade Abdalkareem Jasim, Abdulrahman T. Ahmed, Aziz Kubaev, et al.
Medical Oncology (2024) Vol. 41, Iss. 11
Closed Access | Times Cited: 2
Saade Abdalkareem Jasim, Abdulrahman T. Ahmed, Aziz Kubaev, et al.
Medical Oncology (2024) Vol. 41, Iss. 11
Closed Access | Times Cited: 2
Unlocking the full potential of memory T cells in adoptive T cell therapy for hematologic malignancies
Dongdong Sun, Yijie Hu, Xin Li, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113392-113392
Closed Access | Times Cited: 2
Dongdong Sun, Yijie Hu, Xin Li, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113392-113392
Closed Access | Times Cited: 2
Ultrasensitive quantification of PD-L1+ extracellular vesicles in melanoma patient plasma using a parallelized high throughput droplet digital assay
Hanfei Shen, Yasemin Atiyas, Zijian Yang, et al.
Lab on a Chip (2024) Vol. 24, Iss. 14, pp. 3403-3411
Open Access | Times Cited: 1
Hanfei Shen, Yasemin Atiyas, Zijian Yang, et al.
Lab on a Chip (2024) Vol. 24, Iss. 14, pp. 3403-3411
Open Access | Times Cited: 1
Tumor-derived Exosomes and Antitumor Immunity
Theresa L. Whiteside
The Journal of Immunology (2024) Vol. 213, Iss. 7, pp. 923-931
Closed Access | Times Cited: 1
Theresa L. Whiteside
The Journal of Immunology (2024) Vol. 213, Iss. 7, pp. 923-931
Closed Access | Times Cited: 1
Engineered Cellular Therapies for the Treatment of Thoracic Cancers
Spencer M Erickson, Benjamin M. Manning, Akhilesh Kumar, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 35-35
Open Access
Spencer M Erickson, Benjamin M. Manning, Akhilesh Kumar, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 35-35
Open Access
